Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation

Published:2018-09-19 Issue:5 Volume:234 Page:6361-6370
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Zhang Meng¹²,Cong Qing¹²,Zhang Xiao‐Yan¹²³^ORCID,Zhang Ming‐Xing¹²,Lu Ying‐Ying¹²,Xu Cong‐Jian¹²³^ORCID

Affiliation:

1. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University Shanghai China

2. Department of Obstetrics and Gynecology of Shanghai Medical School Fudan University Shanghai China

3. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27369

Reference28 articles.

1. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

2. Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease

3. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

4. The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer

5. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Resistance and Metabolism: Simplification of Complexity;Cancers;2024-09-04

2. Glycolysis, the sweet appetite of the tumor microenvironment;Cancer Letters;2024-09

3. Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer;Experimental & Molecular Medicine;2024-05-01

4. Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in PreclinicalIn VivoModels: Identification of Targets and New Modalities for Therapeutic Intervention;Cancer Genomics - Proteomics;2024-04-26

5. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance;Cancer and Metastasis Reviews;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3